Takagi Chieko, Sukeda Makoto, Kim Hye-Sook, Wataya Yusuke, Yabe Saori, Kitade Yukio, Matsuda Akira, Shuto Satoshi
Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, 060-0812, Japan.
Org Biomol Chem. 2005 Apr 7;3(7):1245-51. doi: 10.1039/b418829b. Epub 2005 Feb 28.
5'-methylenearisteromycin 5 and its 2-fluoro derivative 6, which were designed as antimalarial agents because of their AdoHcy hydrolase inhibition, were synthesized from D-ribose, using a stereoselective intramolecular radical cyclization as the key step to construct the carbocyclic structure. These compounds were evaluated as AdoHcy hydrolase inhibitors with the recombinant human and malarial parasite enzymes. Although 5 and 6 were both potent inhibitors of the malarial parasite AdoHcy hydrolase, the 2-fluoro derivative 6 proved to be superior due to its lower inhibitory effect on the human enzyme. In addition, 6 was identified as a potent antimalarial agent using an in vitro assay system with Plasmodium falciparum.
5'-亚甲基阿瑞司他霉素5及其2-氟衍生物6因具有腺苷高半胱氨酸水解酶抑制作用而被设计为抗疟药,它们由D-核糖合成,以立体选择性分子内自由基环化作为构建碳环结构的关键步骤。使用重组人源和疟原虫酶将这些化合物评估为腺苷高半胱氨酸水解酶抑制剂。尽管5和6都是疟原虫腺苷高半胱氨酸水解酶的强效抑制剂,但2-氟衍生物6因其对人酶的抑制作用较低而表现更优。此外,在恶性疟原虫的体外检测系统中,6被鉴定为一种强效抗疟药。